Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carbomer 980 is a synthetic, high molecular weight, crosslinked polyacrylic acid polymer used primarily as a thickening, suspending, and stabilizing agent in pharmaceutical and personal care formulations. It is widely employed as an excipient to create clear gels or hydroalcoholic gels and creams due to its efficient rheology-modifying properties[1][2][4]. In pharmaceuticals, it serves as an inactive ingredient in artificial tears for the treatment of dry eyes and has been tested for antiulcerogenic activity[3][5]. Carbomer 980 may also be formulated with other agents such as hydroxypropyl methylcellulose for ocular lubrication. Its mechanism of action is physical—providing viscosity and mucoadhesion rather than pharmacological receptor targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on carbomer 980.